DSM to Invest in Anti-Infectives in China

DSM has signed a contract with North China Pharmaceutical Group Corp. (NCPC; Shijiazhuang) to establish three separate joint ventures with NCPC involving nutritional products and anti-infectives in China. DSM says it will invest a total of $110 million in these initiatives. DSM says it will acquire a minority stake of about 10% in NCPC, a manufacturer of vitamins and antibiotics. The companies will establish a nutrition product jv for vitamin C and two jv’s involving anti-infectives active pharmaceutical ingredients and intermediates. DSM will hold a 51%...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers